Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Solifenacin Succinate”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Early research (Phase 1)Study completedNCT01953861
What this trial is testing

Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Who this might be right for
EC905PharmacokineticsHealthy Subjects
Astellas Pharma Europe B.V. 52
Early research (Phase 1)Study completedNCT01539707
What this trial is testing

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Inc 14
Early research (Phase 1)Study completedNCT01953848
What this trial is testing

Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)

Who this might be right for
EC905PharmacokineticsMultiple Dose+1 more
Astellas Pharma Europe B.V. 27
Early research (Phase 1)Study completedNCT01262391
What this trial is testing

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 42
Early research (Phase 1)Study completedNCT02127034
What this trial is testing

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
Astellas Pharma Europe B.V. 26
Early research (Phase 1)Study completedNCT02010944
What this trial is testing

Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Who this might be right for
Phase 1BioavailabilityHealthy Subjects
Astellas Pharma Europe B.V. 72
Early research (Phase 1)Study completedNCT02169713
What this trial is testing

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
Astellas Pharma Europe B.V. 20
Large-scale testing (Phase 3)Study completedNCT01981954
What this trial is testing

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

Who this might be right for
Neurogenic Detrusor OveractivityPediatric
Astellas Pharma Europe B.V. 23
Large-scale testing (Phase 3)Study completedNCT01565694
What this trial is testing

Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 76
Early research (Phase 1)Study completedNCT01297192
What this trial is testing

A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously

Who this might be right for
Healthy VolunteersPharmacokinetics of Mirabegron
Astellas Pharma Inc 41
Early research (Phase 1)Study completedNCT01953887
What this trial is testing

Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin

Who this might be right for
EC905PharmacokineticsHealthy Subjects
Astellas Pharma Europe B.V. 30
Large-scale testing (Phase 3)Study completedNCT01565707
What this trial is testing

Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Europe B.V. 189
Early research (Phase 1)Study completedNCT01943487
What this trial is testing

Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Who this might be right for
Drug-Drug Interaction (DDI)Healthy Subjects
Astellas Pharma Europe B.V. 36
Early research (Phase 1)Study completedNCT01406158
What this trial is testing

A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

Who this might be right for
Pharmacokinetics of Solifenacin SuccinateHealthy Volunteers
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT01015040
What this trial is testing

Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers

Who this might be right for
Bioavailability of Solifenacin SuccinatePharmacokinetics of Solifenacin SuccinateHealthy Volunteers
Astellas Pharma Inc 24